Dr. Pamela A. Trail


Chief Scientific Officer

Dr. Pamela Trail serves as Chief Scientific Officer of the company since June 2018 and oversees the internal research and development activities including the internal pipeline. Prior to joining Molecular Partners, Dr. Trail served as Vice President Oncology Strategy at Regeneron Pharmaceuticals from August 2010 to March 2017, Vice President Oncology Research at MedImmune from 2008 to 2010, as Founder and Principal of AGL Biotechnology Consultants from 2007 to 2008 and as Chief Scientific Officer at Seattle Genetics from 2006 to 2007. Dr. Trail hold various positions at Bayer Healthcare, including the positions as Global Head, Vice President Protein Therapeutics Research from 2000 to 2006, Global Head Vice President Cancer Research from 2002 to 2004 and Director of Cancer Research from 2000 to 2002. Before joining Bayer, Dr. Trail hold various positions at Bristol-Myers Squibb Pharmaceuticals Research Institute, including the positions as Director of Oncology Cell and Tumor Biology, Group Leader Drug Targeting Research Principal Investigator, Department of Experimental Therapeutics. Dr. Trail received her Ph.D. in 1983 from the University of Connecticut, Storrs, CT and was a postdoctoral Research Fellow at the Memorial Sloan-Kettering Institute for Cancer Research, NY from 1983 to 1986.